Fritextsökning
Innehållstyper
-
ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin
More than 50 distinguished speakers from leading manufacturing companies.
-
Your solution for right part positioning
ZEISS OmniFix CT - right part positioning solution to get meaningful measuring results for all part sizes.
-
Tryggare process med rätt flödesmätare från OEM Automatic
OEM Automatic erbjuder ett omfattande sortiment av flödesmätare från Brooks Instrument – en världsledande tillverkare inom flödesmätning. För att säkerställa en...
-
Sustainability at Festo
On the Way to the Net Zero Era - New Sustainability Report published
-
De fick Swecares exportpris
Två företag mottog priser under Swecares årskonferens.
-
Automated nitrogen analysis reduces costs per sample
N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo
-
ZEISS Quality Innovations at CONTROL
May 6-9, 2025 in Stuttgart.
-
USA och Storbritannien i nytt avtal – nolltullar för läkemedel
USA och Storbritannien har enats om ett handelsavtal som avskaffar amerikanska tullar på brittiska läkemedel och medicintekniska produkter. I utbyte lovar Storb...
-
Multiplex immunofluorescence chemistries with ZEISS tissue multiplexing workflow
Bringing leading multiplex immunofluorescence chemistries together in one automated 8-channel imaging platform.
-
ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA
ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care.
-
Enhance your expertise with your measuring software
Discover the training options in our ZEISS Metrology Portal.
-
AI speeds up measurement process
How to inspect coatings ten times faster with a light microscope? The medical technology group Smith+Nephew has been using ZEISS Axio Imager.Z2m since summer 2022.
-
Beta-blockers are often given unnecessarily, a study finds – “This will affect future practice”
Patients who have suffered a minor heart attack do not benefit from beta-blockers, according to a major new study that may change guidelines for cardiac care.
-
Matti Sällberg om året som kommer: ”Större intresse riktas mot Europa”
Nu nalkas vinterns ledigheter. Det vill Life Science Sweden uppmärksamma genom att ställa bakåt- och framåtblickande frågor till branschprofiler fram till jul. ...
-
Carl Zeiss Meditec achieves revenue growth and stable operating profit
Further recovery in order entry compared to prior year.
-
Verigraft fick Arvid Carlsson-priset
Göteborgsbaserade Verigraft belönas med Arvid Carlsson Award 2025 för ”banbrytande framsteg inom regenerativ medicin”.
-
An organ seldom in the spotlight – but utterly vital
The kidneys consist of more than 40 types of cells and have more functions in the body than most people know. Julie Williams leads AstraZeneca’s work in preclin...
-
ZEISS Smartzoom 100 for Inspection Efficiency
Catch up on our free webinar.
-
Anocca raises SEK 440 million ahead of clinical cancer trial
Swedish cell therapy biotech Anocca has successfully raised SEK 440 million in a new funding round to support upcoming clinical trials in pancreatic cancer.
-
What will be the next big hype after obesity? – An expert panel highlighted their top picks
What will be the next big trend in life science? Everything from Alzheimer’s, Crispr and Omics were highlighted when the issue was debated at this year’s major ...
-
Discover ZEISS ZEN core – now for electron microscopy
Watch the recording of our free webinar.
-
Driftsäkra kabelkontakter från Molex – anpassade för tuffa miljöer
När kraven på driftsäkerhet är höga är valet av rätt kontakt avgörande. OEM Automatic erbjuder kabelkontakter från Molex – robusta och användarvänliga lösningar...
-
Maximal prestanda i varje massaprocess – möt Waukesha U2 ND
I den krävande världen av pappers- och massaproduktion krävs utrustning som levererar hållbarhet, effektivitet och driftsäkerhet.
-
Wegovy approved in the U.S. for treatment of liver disease
The U.S. Food and Drug Administration (FDA) has granted accelerated approval for Novo Nordisk’s drug Wegovy to treat the serious liver condition known as MASH. ...
BREAKING